Juan P Cata

Aug 25, 2023 | thelancet.com | David Conen |Michael Wang |Giovanni Landoni |Juan P Cata

Background Higher levels of inflammatory biomarkers are associated with an increased risk of perioperative atrial fibrillation and myocardial injury after non-cardiac surgery (MINS). Colchicine is an anti-inflammatory drug that might reduce the incidence of these complications. Methods COP-AF was a randomised trial conducted at 45 sites in 11 countries.